{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:30:48Z","timestamp":1791117048552,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T00:00:00Z","timestamp":1243382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0005715","type":"journal-article","created":{"date-parts":[[2009,5,26]],"date-time":"2009-05-26T17:01:52Z","timestamp":1243357312000},"page":"e5715","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":51,"title":["Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor Cells"],"prefix":"10.1371","volume":"4","author":[{"given":"Enken","family":"Drecoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian C.","family":"Gaertner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Miederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Blechert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Vallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Alke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Seidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bruchertseifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reingard","family":"Senekowitsch-Schmidtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Essler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,5,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.1064126","article-title":"Tumor therapy with targeted atomic nanogenerators.","volume":"294","author":"MR McDevitt","year":"2001","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.addr.2008.04.009","article-title":"Realizing the potential of the Actinium-225 radionuclide generator in targeted \u03b1-particle therapy applications.","volume":"60","author":"M Miederer","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"ref3","first-page":"5084","article-title":"Targeted actinium-225 in vivo generators for therapy of ovarian cancer.","volume":"63","author":"PE Borchardt","year":"2003","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00259-003-1413-9","article-title":"Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using <sup>149<\/sup>Tb-rituximab.","volume":"31","author":"GJ Beyer","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/108497804323071904","article-title":"Radioimmunotherapy of human colon carcinoma xenografts using a <sup>213<\/sup>Bi-labeled domain-deleted humanized monoclonal antibody.","volume":"19","author":"D Milenic","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4161\/cbt.6.6.4089","article-title":"Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma.","volume":"6","author":"C Raja","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijrobp.2007.06.023","article-title":"Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.","volume":"69","author":"S Palm","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","first-page":"67S","article-title":"Candidates for peptide receptor radiotherapy today and in the future.","volume":"46","author":"JC Reubi","year":"2005","journal-title":"J Nucl Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1158\/1078-0432.CCR-07-4647","article-title":"Preclinical Evaluation of the {alpha}-Particle Generator Nuclide <sup>225<\/sup>Ac for Somatostatin Receptor Radiotherapy of Neuroendocrine Tumors.","volume":"14","author":"M Miederer","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nucmedbio.2006.11.006","article-title":"Somatostatin-receptor-targeted alpha-emitting <sup>213<\/sup>Bi is therapeutically more effective than beta(-)-emitting <sup>177<\/sup>Lu in human pancreatic adenocarcinoma cells.","volume":"34","author":"TK Nayak","year":"2007","journal-title":"Nucl Med Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/380364a0","article-title":"Organ targeting in vivo using phage display peptide libraries.","volume":"380","author":"R Pasqualini","year":"1996","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/scbi.2000.0334","article-title":"Targeting tumor vasculature with homing peptides from phage display.","volume":"10","author":"E Ruoslahti","year":"2000","journal-title":"Semin Cancer Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.279.5349.377","article-title":"Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.","volume":"279","author":"W Arap","year":"1998","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1073\/pnas.062189599","article-title":"A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo.","volume":"99","author":"K Porkka","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1083\/jcb.200304132","article-title":"Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels.","volume":"163","author":"S Christian","year":"2003","journal-title":"J Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1096\/fasebj.13.14.1911","article-title":"Molecular dissection of nucleolin&apos;s role in growth and cell proliferation: new insights.","volume":"14","author":"M Srivastava","year":"1999","journal-title":"FASEB J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"12617","DOI":"10.1073\/pnas.152463399","article-title":"Nanocrystal targeting in vivo.","volume":"99","author":"ME Akerman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia.","volume":"4","author":"O Glehen","year":"2004","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/17425247.4.4.389","article-title":"The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis.","volume":"4","author":"AJ Gunn","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1021\/ac0580114","article-title":"Production of Ac-225 from Th-229 for targeted alpha therapy.","volume":"77","author":"C Apostolidis","year":"2005","journal-title":"Anal Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/07366290701285108","article-title":"An improved Method for the Production of Ac-225\/Bi-213 from Th-229 for Targeted Alpha Therapy.","volume":"25","author":"B Zielinska","year":"2007","journal-title":"Solvent Extraction and Ion Exchange"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.ccr.2006.02.032","article-title":"Bismuth(III) complexes with aminopolycarboxylate and polyaminopolycarboxylate ligands: Chemistry and structure.","volume":"250","author":"V Stavila","year":"2006","journal-title":"Coordination Chemistry Reviews"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1091\/mbc.E07-10-1018","article-title":"Cell cycle-dependent binding of HMGN proteins to chromatin.","volume":"19","author":"S Cherukuri","year":"2008","journal-title":"Mol Biol Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1349-7006.2007.00525.x","article-title":"<sup>213<\/sup>Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude mice.","volume":"98","author":"R Beck","year":"2007","journal-title":"Cancer Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00259-006-0311-3","article-title":"Non-invasive visualisation of development and peritoneal carinomatosis and tumor regression after <sup>213<\/sup>Bi-radioimmuntherapy using bioluminescence imaging.","volume":"34","author":"HM Buchhorn","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1158\/1078-0432.CCR-1004-0017","article-title":"Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody.","volume":"11","author":"S Bloechl","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref27","first-page":"1867","article-title":"Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.","volume":"47","author":"MJ Koppe","year":"2006","journal-title":"J Nucl Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MNM.0b013e328013e5a8","article-title":"Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model.","volume":"28","author":"S Kinuya","year":"2007","journal-title":"Nucl Med Commun"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0005715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T06:28:14Z","timestamp":1558333694000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0005715"}},"subtitle":[],"editor":[{"given":"Eric J.","family":"Bernhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,5,27]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,5,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0005715","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,27]]}}}